Hormone receptor-positive breast cancer were relatively advanced cases of early breast cancer that require chemotherapy, whereas hormone receptor-negative breast cancer was excluded if the cancer is so small that NAC is not required, as well as elderly patients or patients with comorbidities who cannot tolerate NAC. Here, NR4A1 is linked to cancer.